Liquid biopsy in malignant primary bone tumors: Clinical applications of circulating tumor DNA and circulating tumor cells for diagnosis, prognosis and treatment monitoring (Review)
Oncology Reports · 12.02.2026 · 55 (4) · 1-15
DOI: 10.3892/or.2026.9077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 12.02.2026. Verfasst von Bin Tian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sports Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Bone Neoplasms, Circulating Tumor DNA, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sports Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China.
Zitieren
APA
Tian, B., Chen, X., Zheng, J., & Kang, X. (2026). Liquid biopsy in malignant primary bone tumors: Clinical applications of circulating tumor DNA and circulating tumor cells for diagnosis, prognosis and treatment monitoring (Review). Oncology Reports, 55(4), 1-15. https://doi.org/10.3892/or.2026.9077
Vancouver
Tian B, Chen X, Zheng J, Kang X. Liquid biopsy in malignant primary bone tumors: Clinical applications of circulating tumor DNA and circulating tumor cells for diagnosis, prognosis and treatment monitoring (Review). Oncology Reports. 2026;55(4):1-15. doi:10.3892/or.2026.9077
BibTeX
@article{Tian2026,
author = {Tian, Bin and Chen, Xuesong and Zheng, Jiang and Kang, Xin},
title = {Liquid biopsy in malignant primary bone tumors: Clinical applications of circulating tumor DNA and circulating tumor cells for diagnosis, prognosis and treatment monitoring (Review)},
journal = {Oncology Reports},
year = {2026},
volume = {55},
number = {4},
pages = {1--15},
doi = {10.3892/or.2026.9077}
}
EUVIMED